Notice of Change to the Award Budget for RFA-DK-14-010 "(Re) Building a Kidney: Cells to Organ (UH2/UH3)"
Notice Number:
NOT-DK-14-026
Key Dates
Release Date: September 25, 2014
Related Announcements
Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Purpose
The purpose of this Notice is to amend the budgetary limits language for RFA-DK-14-010 "(Re)Building a Kidney: Cells to Organ (UH2/UH3)".
Part. 2. Section II. Award Information
Current language:
Award Budget |
The direct costs for UH2 awards are expected to be approximately $200,000-$300,000 per year. Total costs for the entire UH2 phase are limited to $500,000. For the UH3 phase, the direct cost amount is expected to be approximately $500,000-$600,000. Total costs for the UH3 phase are limited to $1.0 million per year. |
Modified language:
Award Budget |
The direct costs for UH2 awards are expected to be approximately $200,000-$300,000 per year. Total costs for the UH2 phase are limited to $500,000 per year. For the UH3 phase, the direct cost amount is expected to be approximately $500,000-$600,000. Total costs for the UH3 phase are limited to $1.0 million per year. |
All other aspects of this Funding Opportunity Announcement remain unchanged.
Inquiries
Please direct all inquiries to:
Deborah K. Hoshizaki
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-7712
Email: deborah.hoshizaki@nih.gov
and Human Services (HHS)
